Biotech Firm Omega Therapeutics Gets OK For Ch. 11 Plan
A Delaware bankruptcy judge approved biotechnology developer Omega Therapeutics' Chapter 11 plan Wednesday, after no objections to the company's plan to distribute its remaining assets were raised at a brief hearing....To view the full article, register now.
Already a subscriber? Click here to view full article